Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03056352 · ClinicalTrials.gov registry record · Phase 1
Metoclopramide for Post-Traumatic Headache. A Pilot Study
A Phase 1 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT03056352 is a Phase 1 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 21 participants.
The verdict
NCT03056352, a Phase 1 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
Post-traumatic headache is common. We are determining short and longer-term outcomes among patients treated for post-traumatic headache with IV metoclopramide.
Interventions
- DRUG Diphenhydramine
- DRUG Metoclopramide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2017-08-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03056352
The ClinicalTrials.gov registry entry for NCT03056352 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Diphenhydramine is the first listed.
NCT03056352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03056352 about?
NCT03056352 is a clinical study titled "Metoclopramide for Post-Traumatic Headache. A Pilot Study". Post-traumatic headache is common. We are determining short and longer-term outcomes among patients treated for post-traumatic headache with IV metoclopramide.
What is the current status of trial NCT03056352?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2017-03-01. Estimated completion is 2017-08-15.
What interventions are being tested in trial NCT03056352?
The interventions under investigation include: Diphenhydramine (DRUG), Metoclopramide (DRUG).
Who is sponsoring clinical trial NCT03056352?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.